Cochrane US and Lifeology hosted an International Women's Day themed #sciart challenge. The two winning designs have been selected and added to the Cochrane Store. 

For International Women’s Day (IWD) on March 8th, Cochrane hosted several free events, including an art and graphic challenge with Cochrane US and Lifeology to illustrate the theme of IWD for 2022: #BreakTheBias. The art or graphic had to be related to healthcare and/or evidence synthesis.

Two amazing designs were selected and we spoke to the artists to learn more about the meaning behind the designs. 

This pen and ink piece has to do with the personal geographies of women navigating their own bodies, health science, and economic access within what seems at times like an ocean wave or radio wave of fluidity. It represents the collaborative of women, building on each other's successes, and rising to higher peaks of understanding.

Shauna Lee Lange is the founder of Steam Creatives. She is an artist, analyst, and advisor with over 30 years experience in creative industries and government regulatory oversight. In 2005, she combined work in both fields to concentrate on a range of activities from self-taught professional artist, curator, and show producer to inside art influencer in the global art market. The digital component of her expert art advisory services known as Metaverse Watchdogs tracks the NFT, NFT art, crypto art, and blockchain art spaces. Steam Creatives was born out of a need to find a home for art that centered on visual communication within science and technology. Lange makes her home on Central California's coast, a place of much untouched natural beauty. You can view more of Shauna's work on the Steam Creatives website:  https://steamcreatives.com/

Three women from diverse backgrounds strike the "Break the Bias pose". Each of the women are stacked on top of one another so their crossed arms form the crossings of a double helix. The rest of the DNA strands are filled with small science-themed doodles coloured in black.

Abbey Morris is a recent graduate from the Master of Science Communication program at Laurentian University in Canada. She loves science communication because it allows her to bridge her interests in art, science, and social justice. Abbey strives to make scicomm a more equitable, diverse, and inclusive space for people to share their passion for science in creative and engaging ways. You can find more of Abbey's work on her website: https://abbeymor.wixsite.com/home 

Lina Cellante is a medical biotechnologist currently cutting her teeth in the medical writing world. In her previous life she was a researcher dealing with drug delivery and nanoparticles to fight brain cancer. During the years spent in the lab, she felt a growing need to better communicate her daily work and to find a way to interact more effectively with other scientists. After her Master's degree, she graduated in Journalism and Science communication and worked at the European Commission as a scientific communication officer. She has always been passionate about writing and her interests are nutrition, its positive influence on body health and mind, and how to make the most out of the technology we have to stimulate curiosity and convey positive messages. You can find more of Lina's work on her Lifeapp space: https://lifeapps.io/author/healthbites/

These designs are now available for a limited time in the Cochrane Store - on totes, t-shirts, and mugs! 

Friday, March 25, 2022

Wednesday, March 9, 2022

A statement from Cochrane's Governing Board: 

"Ukraine situation: Cochrane is an independent, diverse, global organization that collaborates to produce trusted synthesized evidence, make it accessible to all, and advocate for its use. Our guiding principles include participation, collaboration and access.   We endorse peace, and share the World Health Organization's concern for the health of those affected.

Cochrane and Wiley provide one-click free access to the Cochrane Library for Ukraine via IP recognition. There is also full text access available through a partnership with Research4Life for Refugee Camps recognized by UNRWA or categorized by UNHCR as 'planned/managed camps.'"

 

Tuesday, March 8, 2022

With the new feature of including PICO terms on review pages, you will be able to find the most relevant Cochrane evidence to answer your research or clinical question.

One way to construct a well-built question is to use the PICO model. PICO stands for Population, Intervention, Comparison, and Outcomes. 

• Population (or Patient or Problem) What are the characteristics of the patient or population – for example condition?
• Intervention What is the intervention under consideration for this patient or population – for example a drug or surgical intervention?
• Comparison What is the alternative to the intervention ¬– for example a different drug or a placebo?
• Outcome What are the relevant outcomes – for example quality of life or adverse events?

Cochrane's Information Specialists and Data Curation Specialists have annotated the PICO terms of Cochrane Reviews using the Cochrane Vocabulary.

"Adding PICO summaries to Cochrane reviews will make Cochrane evidence more accessible and increase its use in health and care decisions, which is part of Cochrane’s mission.” says Cochrane’s Editor in Chief, Dr Karla Soares-Weiser.

PICO Search
You can already use PICO Search to find reviews in which the search term is used as a Population, Intervention, Comparison, or Outcome. For example, PICO Search enables you to find reviews which consider Diabetes specifically as a Population component or alternativity as an Outcome component, therefore enabling you to search with precision on the PICO terms which are of specific interest.

PICO at-a-glance
Every Cochrane Review from 2015 onwards will now have the PICO terms listed under the abstract. This PICO overview helps ensure you find the most relevant Cochrane evidence to answer your research or clinical question. You will also be able to click on the individual PICO terms to see search results for all our Reviews tagged with that PICO term. 

“We worked directly with users of the Cochrane Library to learn about what improvements they wanted and how we could improve their journey on the site” said Rachel Craven, Head of Cochrane Library. “Having PICO terms expertly annotated in Cochrane Reviews can help answer your research and clinical questions – we’re excited to see them now prominently placed below each Cochrane Abstract.”

• Explore Cochrane Review on the Cochrane Library 
• How to conduct a PICO Search
• Conduct a PICO Search

Wednesday, March 16, 2022

Dizajn okoline u ustanovama za starije i nemoćne kako bi se poboljšala kvaliteta života starijih ljudi Koji je cilj ovog sustavnog pregleda? Populacija starijih osoba je u porastu na svjetskoj razini, kao i broj osoba koje pate od demencije. Postoje naznake da poboljšanje i promjena dizajna okoline u kojoj oni žive može poboljšati kvalitetu života, raspoloženje i mogućnost obavljanja svakodnevnih aktivnosti u starijih osoba koje žive u ustanovama za starije i nemoćne. Cilj ovog sustavnog pregleda bio je procijeniti učinak različitih okolišnih intervencija u ustanovama za zdravstvenu njegu...

76% of new guidelines issued by WHO referenced Cochrane reviews in 2021.

Cochrane’s status as a non-governmental organization (NGO) in official relations with the World Health Organization (WHO) was recently renewed at WHO’s Executive Board meeting.

The official relation status enables us to join and make statements at key WHO meetings as a non-voting participant. This includes the World Health Assembly (WHA), WHO’s decision-making body, which is attended by representatives of all Member States, and is a key forum to advocate for evidence-informed health policies.

The renewal is also underpinned by a new joint plan of work for the next three years. Activities in the plan include:

• Providing relevant evidence synthesis and methodological support for consideration in the development of new WHO guidelines, the Essential Medicines List and other guidance
• Supporting WHO with training in the interpretation of evidence synthesis
• Contributing to activities which facilitate the use of evidence in policymaking at national, regional and global levels
• Collaboration on areas of mutual interest, including on essential medicines and diagnostics; research integrity; healthy ageing; reproductive health and nutrition

WHO is a key partner for Cochrane. This relationship enables us to provide input on the way research evidence is identified, synthesized, assessed and used by WHO – and ultimately contribute to improved health for all.

Use of Cochrane evidence in WHO guidance: in figures

Cochrane has been in official relations with WHO since 2011. As of 1 February 2022, 732 reviews from 47 Cochrane Review Groups (CRGs) have been used to inform 251 WHO accredited guidelines and other evidence-based recommendations.

In 2021, 76% of new WHO guidelines were informed by evidence from Cochrane reviews. A total of 78 reviews from 16 different CRGs are referenced.

Cochrane reviews have also been used in WHO’s COVID-19 technical guidance. Last year, a total of 13 reviews were used across 20 of WHO’s COVID-19 publications.

Cochrane is proud to be a core partner of the Evidence Collaboration on COVID-19 (ECC-19), coordinated by the WHO Science Division. We were also delighted that WHO was a co-sponsor of Cochrane Convenes and we hope to collaborate further in taking forward some of the recommendations in the resulting Call to Action.

A community effort

The relationship with WHO is supported by the efforts of many members of the Cochrane community. Thank you to everyone who has contributed to this ongoing, impactful work. Particular thanks also go to Emma Carter and Anne Eisinga at Cochrane UK for their work in charting how Cochrane reviews are used in WHO guidelines and other technical guidance.

For more information on the work that Cochrane does with WHO, please get in touch with Emma Thompson, Cochrane’s Advocacy and Partnerships Manager.

Read our statements made at recent major WHO events

• Cochrane makes statement to special session of the World Health Assembly
• Cochrane’s statement to the 74th World Health Assembly
• Cochrane statement to the 148th WHO Executive Board meeting on strengthening global emergency preparedness

Wednesday, March 9, 2022

Friday, March 4, 2022

Sprječavaju li lijekovi za razrjeđivanje krvi razvoj krvnih ugrušaka kod osoba koje su hospitalizirane s COVID-19? Ključne poruke - Visoke doze lijekova za razrjeđivanje krvi naspram niskih doza čine malu ili nikakvu razliku u stopi smrtnosti te povećavaju broj manjih krvarenja u pacijenata hospitaliziranih s COVID-19. Davanje lijekova za razrjeđivanje krvi u usporedbi s njihovim nedavanjem može smanjiti stopu smrtnosti. - Vrlo je vjerojatno da nova ispitivanja neće promijeniti dokaze o učincima različitih doza lijekova za razrjeđivanje krvi na smrtnost i manja krvarenja. I dalje su potrebna...

Koje su prednosti, a koji rizici topikalnih lijekova u liječenju epidemijskog keratokonjunktivitisa? Što je epidemijski keratokonjunktivitis? Epidemijski keratokonjunktivitis je upala spojnice (konjunktive), membrane koja prekriva skleru ili bjeloočnicu (bijeli vanjski omotač oka) te unutrašnjost kapaka, a obično ju uzrokuju specifični sojevi adenovirusa. Infekcija se lako širi unutar kućanstava, zdravstvenih ustanova i zajednice. Kod nekih pojedinaca, upala dovodi i do stvaranja ožiljkastog tkiva na rožnici (tzv. infiltrata) i konjunktivi, što uzrokuje trajnu nelagodu i oslabljeni vid. Kako...

We are pleased to share the winners of the 2021 Cochrane-REWARD prize.

The Cochrane-REWARD prize recognizes successful local or pilot initiatives that have potential to reduce research waste globally if scaled up. Cochrane has funded the prize since it began in 2017. For this iteration of the prize, submissions related to tackling research waste relevant to COVID-19 were encouraged.

The prize ceremony took place on 1 March virtually (recordings are available below). Two representatives of the prize committee – Matt Westmore, Chief Executive of the UK Health Research Authority, and Lex Bouter, Professor of Methodology and Integrity at Vrije Universiteit Amsterdam – joined to announce the winners, who gave short presentations on their initiatives. Lisa Bero, Cochrane’s Senior Research Integrity Editor, also joined the session to give an update on Cochrane’s research integrity agenda.

2021 Cochrane-REWARD prize winners
This year was particularly competitive, with many very strong contenders for the prize committee to consider. Thank you to all who submitted nominations, and congratulations to the winners below:

First prize: COVID-END
The COVID-19 Evidence Network to support Decision-making (COVID-END) was awarded first prize. Jeremy Grimshaw and John Lavis accepted the prize on behalf of the network.

COVID-END is a time-limited network of 58 global evidence synthesis, guidance and decision support partner organizations established to better coordinate the evidence synthesis response to the COVID-19 pandemic and reduce research waste.

Together with its partners, COVID-END has worked to reduce waste in all five stages of research. Selected highlights include:

• Setting up a global horizon scanning panel to proactively identify recurrent and emerging issues requiring evidence syntheses in the coming months.
• Developing interactive flow-diagrams for researchers and guideline developers planning to work on a new review or guideline pointing them to helpful resources, while encouraging them to ensure that they are not duplicating the efforts of another group.
• Creating an inventory of best evidence syntheses highlighting quality up-to-date living syntheses that make it easier for decision makers to find the best evidence.
• Establishing a COVID-END community and living hub of COVID-19 knowledge hubs to link evidence synthesis, guidance and decision-support groups around the world interested in learning from others and sharing best practices.
• Providing the foundation for the Global Commission on Evidence to Address Societal Challenges, a report which aims to seize on the once-in-a-generation focus on evidence presented by the pandemic, calling for sustained efforts to systematize the successful aspects of using evidence and to address the shortfalls.

The prize committee was particularly impressed with COVID-END’s global reach, which includes participation from low- and middle-income countries (LMICs). The committee also saw that such an approach could be adapted and deployed for other crises in the future.

Second prize: MRC-NIHR Trials Methodology Research Partnership
The MRC-NIHR Trials Methodology Research Partnership (TMRP) received the second prize. Paula Williamson accepted the prize on behalf of the initiative.

TMRP is a community of practice which draws together several networks, academic institutions and partners engaged in trials and trials methodology research to strengthen links between trialists, methods researchers, clinicians, patients, the public and funders. It includes eight thematic working groups on topics such as adaptive designs, outcomes, statistical analysis and trial conduct.

As well as leading to more impactful research and less duplication of effort, better networking facilitated by TRMP enabled researchers to pivot and respond to the COVID-19 pandemic.

Selected network projects include:

• A priority-setting exercise to develop a trials methodology research agenda, feeding more specific exercises for recruitment and retention research, patient and public involvement in methods research, and priorities for methods research in LMICs.
• Designing clinical trials, including several platform trials of potential COVID-19 treatments, including the RECOVERY, AGILE, and HEAL-COVID trials.
• Developing COVID-19 core outcome sets (COS), including a ‘meta-COS’ for acute COVID-19, a COS for COVID-19 transmission prevention and a COS for Long COVID.
• Producing guidance and tools for researchers to support transparent and complete reporting of research.

The panel was very impressed with TRMP’s large body of work to date. We saw great potential to improve the overall standards of trial design, analysis and reporting if the approach were to be scaled up across further contexts.

Thank you to the Cochrane-REWARD prize committee
Special thanks to the Cochrane-REWARD prize committee for reviewing the entries during what was an especially competitive year for the prize. In 2021, the prize committee was:

• Lex Bouter, Professor of Methodology and Integrity, Vrije Universiteit Amsterdam
• Sabine Kleinert (chair), Senior Executive Editor, The Lancet
• Joan Marsh, Editor-in-Chief, The Lancet Psychiatry
• Merel Ritskes-Hoitinga, Professor in Evidence-Based Laboratory Animal Science, Radboud University Medical Center
• Kieron Rooney, Associate Professor, University of Sydney
• Matt Westmore, Chief Executive, UK Health Research Authority

Wednesday, March 2, 2022

Usporedba različitih metoda za određivanje nedostatka kromosomskih krakova 1p i 19q u gliomima Zašto je važno poboljšati otkrivanje 1p/19q kodelecije u gliomu? Gliomi su vrsta tumora (karcinoma) mozga. Postoje različite vrste glioma, s različitim promjenama u njihovom genetskom materijalu. Jedna od mogućih genetskih promjena je gubitak dijelova dvaju od 23 kromosoma. Nedostatak specifičnih dijelova kromosoma 1 i kromosoma 19, poznat je kao '1p/19q kodelecija'. Kodelecija 1p/19q koristi se za dijagnosticiranje glioma poznatog kao oligodendrogliom. Prisutnost 1p/19q kodelecije može nam reći...

Covidence is a web-based software platform that streamlines the production of systematic reviews, including Cochrane Reviews. They have recently announced the launch of the Covidence Global Scholarship Program to financially support the next generation of superstar evidence researchers around the world.  With a $75,000 funding pool they will be supporting  some of the world’s brightest PhD and Masters students so they can spend more time creating knowledge that will make a big impact in the world. 

 

 Applicants to the Covidence Global Scholarship must meet all of the following criteria:

• Be a current PhD or Master by dissertation student of any nationality
• Be enrolled in any discipline at an accredited university during this academic year (2022)
• Be undertaking or will be starting a systematic review as part of the dissertation in the six months following the award (June-Dec 2022)

Covidence will be awarding 52 scholarships in total. Applications are open until Thursday 31st March 11.59pm EST.

• Learn more about the Covidence Global Scholarship Program and apply

 

To support the Global Scholarship Evidence, Covidence is  seeking Expressions of Interest from qualified individuals to serve on the Scholarship selection panel. To be eligible to participate, panel members must hold a Masters or PhD degree, or have equivalent experience. To ensure balanced representation on the panel, they encourage applications from diverse backgrounds and experience. Panel members will receive a USD$1000 honorarium. 

If you have any questions about submitting an Expression of Interest, please contact Nancy Owens, Head of Community Management at Covidence, at nancy@covidence.org. Expressions of interest for panelists close on Thursday, 31 March 2022, at 5.00 pm GMT. 

• Express your interest in becoming a panel member

 

About Covidence: 
Covidence is a SaaS social enterprise platform used around the world and by some of the world’s leading institutions to accelerate the systematic review workflow, making it easier to  turn the flood of new scientific research into high-quality, trustworthy knowledge summaries. Established in 2014,  Covidence provides free access to users in low-income countries and those participating in COVID-19 research.  To find out more about Covidence go to www.covidence.org

Monday, February 28, 2022

Lifeology’s tagline is ‘The place where science and art converge’. They offer a platform that brings together scientists, artists, and storytellers to help people better understand and engage with science and health information and research. One of the main ways they meet their objectives is through beautifully illustrated, science-backed, bite-sized ‘flashcard’ courses about science and health-related topics aimed at the general public and students.

Knowing more about the people in science, technology, engineering, arts, and math (STEAM), how they faced adversity and overcame obstacles may inspire others to choose STEAM careers. This was the goal of Lifeology's Historic STEAM Heros card deck. Though art and storytelling they share the story of historical STEAM figures and their excellent but often under-promoted work.

Anne Anderson is included in this STEAM Heros deck. Anne Anderson was a contributor to the stream of thinking and effort that gave birth to evidence-based health care and led to the development of Cochrane. We spoke with the artist who illustrated the card, Anna Doherty, to learn more about the project. 

Hi, Anna! Our Cochrane Community always finds it interesting to learn the backstory of things and learn more about people. Could you tell us a bit more about yourself?

Hi! I’m an illustrator and author from Edinburgh, Scotland. Ever since I was very small, I’ve always enjoyed drawing, so when I finished school I went to study illustration at Duncan of Jordanstone College of Art and Design. After graduating, I decided to study a masters in Children’s Book Illustration at Cambridge School of Art. Since graduating there, I’ve been working on a mixture of illustrating picture books, science illustration, and other little projects. I now have ten illustrated picture books published, some of which I wrote too! I am especially excited about working in non-fiction, which is why I think I enjoy science illustration so much because I love learning new facts and finding fun new things to share with people. I have a mini-series called Fantastically Feminist which focuses on celebrating stories of amazing women. I wanted to make space for kids to read in not only showed that everyone should be equal and that anyone can do anything regardless of their gender, but also celebrated women who struggled to try and make things more equal for the rest of us in brilliant ways.

What an interesting mix of projects! How would you describe your art style?

I would describe my art style as digital mixed media. I usually draw on a Wacom tablet, which is connected to my computer. When I draw on the tablet, the marks I’m making come up on my screen in photoshop. I use a selection of brushes and add scanned textures that I’ve made with ink and paint to add some interest.

You’ve done some science communication and some lovely ‘Women in STEAM’ work. Can you tell us how you got into that? 

I got into science communication through my picture book Ada Lovelace. I had always loved maths at school, so when I first heard about Ada, I was fascinated, and I started absorbing every fact about her that I could lay my hands on. After I published my book about her, it opened the door to the world of science illustration, and I was particularly excited about promoting more women in STEAM. Ada’s work wasn’t really recognised until after her death, so it’s amazing to be able to celebrate women and gender-diverse scientists who are working today!

Anne Anderson is a beloved person in the Cochrane Community - we do a walk every year in her honour to raise money for an annual award in her name. Can you tell us a bit about working on that artwork?

I loved working on Anne Anderson’s illustration because she wasn’t a story I had explored before. It was fun to draw a Scottish scientist! I started by reading the research that Lifeology had collated already, and did a little more digging myself. With every ‘Historic STEAM Hero’ illustration, I start by drawing the portrait so I can get to know the person a little better first. Then I make a little list of the key things I want to include in the illustration, and think about how I can represent them. Because I work digitally, I tend to draw all the little icons first and then move them around the face to find the best composition. Each illustration is greyscaled with one colour, and I chose purple for Anne because it’s the colour of International Women’s Day and represents Cochrane! 

• Visit Anna’s website
• Follow Anna on Instagram, Twitter, or TikTok
• View Lifeology's Historic STEAM Heros card deck

Wednesday, March 8, 2023

Assistant Managing Editor/Information Specialist, fixed term to 31 March 2023
Deadline to apply: 7 March 2022
London, UK

Cochrane Neuromuscular is seeking an Information Specialist/Assistant Managing Editor on a fixed-term basis to 31 March 2023. This is an opportunity to contribute to evidence synthesis for the benefit of people affected by neuromuscular diseases.

Cochrane Neuromuscular is part of Cochrane, an independent, global organisation dedicated to synthesising research evidence to improve health. The group publishes reviews of evidence in neuromuscular disease in The Cochrane Database of Systematic Reviews (CDSR). Cochrane Neuromuscular is hosted by University College London NHS Hospitals Trust.

As postholder, you will have two primary areas of responsibility: literature searching, and assisting the Managing Editor in the management of submitted reviews. You will develop search strategies, run searches, and ensure correct documentation. Editorial tasks will include providing information to authors, checking manuscripts, overseeing peer review, tracking progress, and liaising between authors, editors, and reviewers. The appointee will also provide the review group with administrative support and may have the opportunity to assist review authors with systematic review tasks.

For details see nhsjobs.com. Closing date 7 March 2022.

Monday, February 28, 2022 Category: Jobs

Jesu li lijekovi protiv zgrušavanja krvi korisni za osobe s kroničnom bolešću bubrega? Što je proučavano u ovom sustavnom pregledu? Osobe s kroničnom bolešću bubrega (CKD, prema engl. chronic kidney disease) imaju povećan rizik od srčanih bolesti koje mogu blokirati dotok krvi u srce ili mozak, što uzrokuje srčani ili moždani udar. Lijekovi koji sprječavaju stvaranje krvnih ugrušaka (antitrombocitni lijekovi) mogu spriječiti smrt koju uzrokuju ugrušci u arterijama u općoj odrasloj populaciji. Međutim, osobe koje imaju CKD mogu imati manje koristi od tih lijekova, jer su kod njih krvni...

Imunosupresivno liječenje za fokalnu segmentalnu glomerulosklerozu u odraslih Što je proučavano u ovom sustavnom pregledu? Nefrotski sindrom je stanje u kojem bubrezi propuštaju proteine iz krvi u mokraću. Fokalna segmentalna glomeruloskleroza (FSGS) potvrđena na biopsiji bubrega neuobičajen je uzrok nefrotskog sindroma, ali napreduje do zatajenja bubrega u otprilike polovici svih slučajeva. Može se podijeliti u tri skupine - primarni FSGS (misli se da je posljedica čimbenika koji cirkulira u krvi koji oštećuje bubrege), genetski (zbog mutacija u jednom ili više gena) i sekundarni zbog...

Metilfenidat s produljenim otpuštanjem za poremećaj s nedostatkom pažnje i hiperaktivnošću (ADHD) u odraslih Cilj sustavnog pregleda Ovaj sustavni pregled istražio je pozitivne i negativne učinke metilfenidata i usporedio ih s placebom ili drugim lijekovima kod odraslih osoba kojima je dijagnosticiran poremećaj s nedostatkom pažnje i hiperaktivnošću (engl. attention deficit hyperactivity disorder, ADHD). Posebna pažnja bila je usmjerena na učinke na svakodnevno funkcioniranje, kao što je broj dana izostanaka s posla i učinke na simptome ADHD-a i kvalitetu života koje procjenjuju sami...

Planiranje otpusta iz bolnice Koji je cilj ovog Cochraneovog sustavnog pregleda? Cilj Cochraneovog sustavnog pregleda bio je otkriti može li planiranje otpusta koje je prilagođeno pojedincu poboljšati kvalitetu pružene zdravstvene skrbi, smanjenjem odgođenog otpusta iz bolnice, smanjivanjem stope vraćanja u bolnicu i poboljšanjem zdravstvenog stanja pacijenata. Zanimalo nas je i koliko košta takva intervencija. Prikupili smo i analizirali sva relevantna istraživanja kako bismo odgovorili na ovo pitanje. Ovo je peto obnavljanje originalne inačice pregleda. Ključne poruke Kada ljudi napuste...

Učinci prehrane sa smanjenim udjelom glutena ili bez glutena za primarnu prevenciju kardiovaskularnih bolesti Dosadašnje spoznaje Kardiovaskularne bolesti poremećaji su srca i krvnih žila, uključujući akutne koronarne i cerebrovaskularne događaje (kao što su infarkt miokarda i moždani udar). Otprilike 50% invaliditeta uzrokovanih kardiovaskularnim bolestima povezano je s manjkavom prehranom. To se posebno odnosi na prehrambeni gluten (protein koji se nalazi u određenim žitaricama) koji je povezan s velikim brojem nepovoljnih zdravstvenih ishoda. Na primjer, različiti probavni simptomi (kao...

• Full time fixed term until February 2023 (possibility of extension)
• Great opportunity for an early career researcher to join a supportive and well respected team, making an impact in health based research
• Base Salary $98,645 + 17% superannuation
• Applications Close: Sunday 27 February 2022

About the opportunity
The NHMRC Clinical Trials Centre has an exciting opportunity for a Postdoctoral Research Associate to contribute to a range of projects using NextGen evidence synthesis methodologies and conducting meta-research.

Projects will likely include; finding and implementing ideal strategies in childhood obesity prevention interventions with the TOPCHILD collaboration, assessing eating disorder risk in obesity treatment, and conducting meta-research to find and reduce reasons for research waste and increase collaboration and coordination in research.

This is a research-only position, based at the NHMRC Clinical Trials Centre. The successful applicant will be working in the NextGen Evidence Synthesis team within the Evidence Integration Team. There will be an opportunity to develop NextGen evidence synthesis specialist skills, and to attend academic conferences to present project work. The successful applicant will be expected to make an active contribution to papers and new grant submissions arising from this work.

Your key responsibilities will be to:

• undertake systematic reviews
• work on individual participant data meta-analyses with large data sets
• work with a large number of international collaborators and other stakeholders.

About you

• a strong research background including a PhD qualification and competitive publication track record in a relevant field (systematic reviews, obesity, neonatology, epidemiology, public health, quantitative research or biostatistics)
• formal qualifications in research methods, such as Masters level qualifications in epidemiology, biostatistics or public health is highly desired
• ability to work independently, conceive, initiate, organise and manage projects
• excellent communication and interpersonal skills
• the successful applicant will combine quantitative research skills with excellent communication and scientific writing skills
• experience in systematic reviews and meta-analyses is highly desirable
• experience in research implementation and communication with a broad range of stakeholders (e.g. policy makers, consumers) is desirable, but not essential.

To keep our community safe, please be aware of our COVID safety precautions which form our conditions of entry for all staff, students and visitors coming to campus.

Sponsorship/work rights for Australia
Please note: Visa sponsorship is not available for this position. For a continuing position, you must be an Australian or New Zealand citizen or an Australian Permanent Resident.

Australian Temporary Residents currently employed at the University of Sydney may be considered for a fixed term contract for the length of their visa, depending on the requirements of the hiring area and the position.

Pre-employment checks
Your employment is conditional upon the completion of all role required pre-employment or background checks in terms satisfactory to the University. Similarly, your ongoing employment is conditional upon the satisfactory maintenance of all relevant clearances and background check requirements. If you do not meet these conditions, the University may take any necessary step, including the termination of your employment.

EEO statement
At the University of Sydney, our shared values include diversity and inclusion and we strive to be a place where everyone can thrive. We are committed to creating a University community which reflects the wider community that we serve. We deliver on this commitment through our people and culture programs, as well as key strategies to increase participation and support the careers of Aboriginal and Torres Strait Islander People, women, people living with a disability, people from culturally and linguistically diverse backgrounds, and those who identify as LGBTIQ. We welcome applications from candidates from all backgrounds.

How to apply

• Applications (including a cover letter, CV, and any additional supporting documentation) can be submitted here 
• If you are a current employee of the University or a contingent worker with access to Workday, please login into your Workday account and navigate to the Career icon on your Dashboard.  Click on USYD Find Jobs and apply.
• For a confidential discussion about the role, or if you require reasonable adjustment or support filling out this application, please contact Lena Germinarios, Recruitment Operations, by email to lena.germinarios@sydney.edu.au
• The University reserves the right not to proceed with any appointment.
• Click to view the Position Description for this role.
• Applications Close Sunday 27 February 2022 11:59 PM

Tuesday, February 22, 2022 Category: Jobs